Karoo Health
Develops AI healthcare technology, backed by a $16.2 million Series A co-led by 7wire Ventures and Allumia Ventures.
Overview
Karoo Health is an AI healthcare company with limited product detail disclosed in the provided funding context. The company appears to serve the healthcare market, though its specific platform capabilities, customer segment and deployment model were not specified. The company announced an oversubscribed $16.2 million Series A co-led by 7wire Ventures and Allumia Ventures. The round accounts for its disclosed funding to date and signals investor interest despite the absence of stated technical differentiators in the available information.
Funding History
Karoo Health Announces Oversubscribed $16.2 Million Series A Co-Led by 7wire Ventures and Allumia Ventures
Frequently Asked Questions
- How much funding does AI Funding track for Karoo Health?
- AI Funding tracks $16M for Karoo Health across 1 funding round in this database.
- Who are Karoo Health's investors?
- Karoo Health's investors include 7wire Ventures, Allumia Ventures.
- What does Karoo Health do?
- Karoo Health is an AI healthcare company with limited product detail disclosed in the provided funding context. The company appears to serve the healthcare market, though its specific platform capabilities, customer segment and deployment model were not specified. The company announced an oversubscribed $16.2 million Series A co-led by 7wire Ventures and Allumia Ventures. The round accounts for its disclosed funding to date and signals investor interest despite the absence of stated technical differentiators in the available information.
- Where is Karoo Health headquartered?
- Karoo Health is headquartered in San Francisco, CA.
Related Insights
A data-driven analysis of AI funding across all 17 sectors — from Foundation Models to AI Healthcare — with sector totals, deal counts, top companies, and investment trends for 2026.
A comprehensive, data-driven analysis of AI venture funding in Q1 2026. $25.9 billion raised across 94 deals, with 14 mega-rounds capturing 79.8% of total capital. Europe breaks out with $6.65B, and billion-dollar seed rounds arrive for the first time.
A deep comparison of Science Corp.'s neurotech-driven brain-computer interfaces and Nscale's AI cloud infrastructure, examining how $230M and $2B in recent funding fuel fundamentally different visions of artificial intelligence.